XML 23 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities      
Net income $ 249,624 $ 268,550 $ 319,466
Adjustments to reconcile net income to net cash provided by operations:      
Depreciation and amortization 59,172 59,051 56,583
Stock option expense 26,254 22,502 18,422
Deferred payroll taxes (18,175) (18,175) 36,350
Provision for deferred income taxes 14,827 2,400 1,433
Noncash portion of long-term incentive compensation 6,188 7,745 7,208
(Payments) Litigation settlements   (9,440)  
Proceeds Litigation settlements 4,000   2,684
Noncash directors' compensation 1,170 1,173 1,171
Amortization of debt issuance costs 342 306 306
Changes in operating assets and liabilities:      
(Increase)/decrease in accounts receivable (2,414) (8,431) 12,773
(Increase)/decrease in inventories (162) (3,014) 367
Decrease/(increase) in prepaid expenses 2,397 (6,511) (3,027)
Increase in accounts payable and other current liabilities 15,343 9,832 19,096
Change in current income taxes (996) (20,401) 13,525
Net change in lease assets and liabilities 1,471 (44) 1,206
Increase in other assets (45,779) (10,305) (11,834)
(Decrease)/increase in other liabilities (3,350) 12,074 12,323
Other (uses)/sources (26) 1,285 1,237
Net cash provided by operating activities 309,886 308,597 489,289
Cash Flows from Investing Activities      
Capital expenditures (57,325) (58,675) (58,831)
Business combinations, net of cash acquired (3,529)   (3,600)
Proceeds from sale of fixed assets 2,330 904 1,693
Other (uses)/sources (878) 14 (822)
Net cash used by investing activities (59,402) (57,757) (61,560)
Cash Flows from Financing Activities      
Payments on revolving line of credit (306,800) (25,300) (264,900)
Proceeds from revolving line of credit 121,800 210,300 174,900
Proceeds from other long-term debt 100,000    
Payments on other long-term debt (2,500)    
Purchases of treasury stock (114,515) (576,042) (175,594)
Proceeds from exercise of stock options 44,968 35,848 50,382
Dividends paid (22,017) (22,016) (21,079)
Capital stock surrendered to pay taxes on stock-based compensation (15,611) (15,129) (25,328)
Change in cash overdraft payable (11,884) 11,884 (9,849)
Debt issuance costs (1,586)    
Other (uses)/sources (1,108) (165) 256
Net cash used by financing activities (209,253) (380,620) (271,212)
Increase/(decrease) in cash and cash equivalents 41,231 (129,780) 156,517
Cash and cash equivalents at beginning of year 32,895 162,675 6,158
Cash and cash equivalents at end of year $ 74,126 $ 32,895 $ 162,675